Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

ARRY 3.37 -0.11 (-3.16%)
price chart
Stocks Buzz: Array Biopharma Inc (ARRY), Smith & Wesson Holding Corp ...
Array Biopharma Inc (NASDAQ:ARRY)started its trading session with the price of $3.51 and closed at $3.48 by scoring +0.14% and traded with total volume of 894,518.00 shares, while the average trading remained 1.29 million shares.
Related articles »  
Climbing NASDAQ Stocks: Endocyte, Inc.(NASDAQ:ECYT), Array Biopharma Inc ...
The stock has traded within a range of $3.39 to $6.66 over the past 52 weeks. Array Biopharma Inc(NASDAQ:ARRY) currently has a bid price of $3.60 x 3,000 and an offer price of $4.18 x 500.
Related articles »  
Traders Recap - Array Biopharma Inc (ARRY), BioScrip Inc (NASDAQ:BIOS ...
Array Biopharma Inc (NASDAQ:ARRY) Final results from a Phase 2 trial of binimetinib in patients with advanced NRAS mutant melanoma were presented at the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid, Spain.
Morning Summary: UTi Worldwide, Array BioPharma, HMS Holdings, Oncolytics ...
Array BioPharma Inc. (NASDAQ:ARRY) : Announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. The most frequently observed adverse events included acneiform dermatitis, increased blood creatine phosphokinase and peripheral ...
Active Movers � Array Biopharma Inc (NASDAQ:ARRY), ASTELLAS PHARMA ...
Array Biopharma Inc (NASDAQ:ARRY) opened the session at $3.61, trading in a range of $3.33-$3.62, and closed at $3.48. The stock showed a negative performance of -2.52% in the last trading session.
Array Biopharma Hits New 1-Year Low at $3.34 (ARRY)  Watch List News (press release)
Related articles »  
Big Movers: eBay Inc. (NASDAQ:EBAY), Array BioPharma, Inc. (NASDAQ:ARRY ...
Earlier this year, eBay Inc. (NASDAQ:EBAY) waged a costly and bitter campaign dubbed �Better Together� to counter investor Carl Icahn's calls to spin off its PayPal payments unit.
Related articles »  
Stock Summary: Akorn Inc,Alkermes plc,Spectrum Pharma,Sequenom,Array ...
Array BioPharma Inc. (NASDAQ:ARRY) licensed to Novartis (NVS) in 2010, binimetinib is a small molecule selective inhibitor of the kinases MEK1 and MEK2.
Related articles »  
Traders Ditching Biotech Names: VIVUS, Inc. (VVUS), XOMA Corp (XOMA ...
VIVUS, Inc. (NASDAQ:VVUS), XOMA Corp (NASDAQ:XOMA), Array Biopharma Inc (NASDAQ:ARRY), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) all were down as riskier stocks such as technology, ...
Array Biopharma Sets New 52-Week Low at $2.98 (ARRY)
Analysts expect that Array Biopharma will post $-0.79 EPS for the current fiscal year. Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted ...
Array Biopharma Sees Large Increase in Short Interest (ARRY)
Analysts expect that Array Biopharma will post $-0.79 EPS for the current fiscal year. Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted ...
Stocks Buzz � Interface, (NASDAQ:TILE), TrueCar, (NASDAQ:TRUE), Apollo ...  Techsonian (press release)
Related articles »